Tech Company Financing Transactions

Rapalogix Health Funding Round

Rapalogix Health secured a $20 million Series A investment round on 6/23/2026. Backers included GordonMD Global Investments, Woodline Partners and private investors.

Transaction Overview

Company Name
Rapalogix Health
Announced On
6/23/2026
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors

GordonMD Global Investments (Lead Investor)

Woodline Partners (Lead Investor)

Proceeds Purpose
The company intends to use the funds to: Expand its commercial activities for Re-Q. Invest in clinical and translational research. Develop additional products targeting skin longevity, hair health and other age-related changes in skin biology. Expand its scientific, medical and commercial capabilities.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
228 Park Ave S 66643
New York, NY 10003
USA
Phone
(650) 856-3700
Website
www.rapalogix.com
Email Address
[email protected]
Overview
Rapalogix Health is a biotech company focused on translating the powerful learnings from longevity science into transformative solutions for dermatological diseases and skin health, empowering patients to redefine their relationship with their skin and aging. Mission: To deliver advanced, evidence-based solutions that restore and optimize skin at the cellular level, empowering both physicians and patients to achieve holistic and sustainable health and beauty.
Profile
Rapalogix Health LinkedIn Company Profile
Social Media
Rapalogix Health Company Twitter Account
Company News
Rapalogix Health News
Facebook
Rapalogix Health on Facebook
YouTube
Rapalogix Health on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Rahul Mehta
  Rahul Mehta LinkedIn Profile  Rahul Mehta Twitter Account  Rahul Mehta News  Rahul Mehta on Facebook
Chief Financial Officer
Thomas Christenson
  Thomas Christenson LinkedIn Profile  Thomas Christenson Twitter Account  Thomas Christenson News  Thomas Christenson on Facebook
Controller
Kelly Mayo
  Kelly Mayo LinkedIn Profile  Kelly Mayo Twitter Account  Kelly Mayo News  Kelly Mayo on Facebook
VP - Bus. Development
Zhen Cao
  Zhen Cao LinkedIn Profile  Zhen Cao Twitter Account  Zhen Cao News  Zhen Cao on Facebook
VP - Bus. Development
Angela Hildebrand
  Angela Hildebrand LinkedIn Profile  Angela Hildebrand Twitter Account  Angela Hildebrand News  Angela Hildebrand on Facebook
VP - Human Resources
Margaret Kurtz
  Margaret Kurtz LinkedIn Profile  Margaret Kurtz Twitter Account  Margaret Kurtz News  Margaret Kurtz on Facebook
VP - Operations
Johi Greer
  Johi Greer LinkedIn Profile  Johi Greer Twitter Account  Johi Greer News  Johi Greer on Facebook
VP - R & D
Manpreet Randhawa
  Manpreet Randhawa LinkedIn Profile  Manpreet Randhawa Twitter Account  Manpreet Randhawa News  Manpreet Randhawa on Facebook
VP - Regulatory Affairs
Madison Godesky
  Madison Godesky LinkedIn Profile  Madison Godesky Twitter Account  Madison Godesky News  Madison Godesky on Facebook
VP - Sales
Michele Carlo
  Michele Carlo LinkedIn Profile  Michele Carlo Twitter Account  Michele Carlo News  Michele Carlo on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/23/2026: Recykal venture capital transaction
Next: 6/23/2026: Mitigata venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2026. Gaebler Ventures. All rights reserved.